NCT04709432

Brief Summary

It is a cross-sectional study to summarize the extracorporeal membrane oxygenation （ECMO）treatment in children in China.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Jan 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Jan 2021Dec 2026

Study Start

First participant enrolled

January 11, 2021

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

January 13, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 14, 2021

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

March 16, 2026

Status Verified

March 1, 2026

Enrollment Period

6 years

First QC Date

January 13, 2021

Last Update Submit

March 13, 2026

Conditions

Child, OnlyExtracorporeal Membrane Oxygenation

Keywords

Extracorporeal membrane oxygenation; children; complication

Outcome Measures

Primary Outcomes (1)

  • survival rate

    survival rate after discharge

    from admission to discharge （about 10days）

Secondary Outcomes (2)

  • time of running ECMO

    from admission to discharge（about 10days）

  • cost of ECMO treatment

    from admission to discharge （about 10days）

Study Arms (1)

ECMO group

children supported by ECMO in the past 10 years

Procedure: ECMO

Interventions

ECMOPROCEDURE

ECMO is a form of Extracorporeal Life Support (ECLS) to support either the pulmonary, or both the pulmonary and cardiac systems.

ECMO group

Eligibility Criteria

Age1 Day - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

children supported by ECMO in mainland China in the past years

You may qualify if:

  • age of 1d to 18 years old;
  • children supported by ECMO in mainland China in the past 10 years

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Fudan University

Shanghai, Shanghai Municipality, China

RECRUITING

Study Officials

  • Lu Guoping

    Children's Hospital of Fudan University

    STUDY CHAIR

Central Study Contacts

YING JIAYUN

CONTACT

18817583962jiayundoctor@163.com

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 13, 2021

First Posted

January 14, 2021

Study Start

January 11, 2021

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

March 16, 2026

Record last verified: 2026-03

Locations

CN(1)